RPS20P22

Across TCGA pan-cancer cohorts, RPS20P22 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPS20P22 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPS20P22 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS20P22 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

UVM, STAD, and BLCA are the cancer types where RPS20P22 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.396	0.832	<.001	116	view →
STAD	DFS	Tertile	II,III,IV	0.428	0.596	.005	85	view →
BLCA	DFS	Median	II,III,IV	0.563	0.662	.009	44	view →
LGG	DFS	Median	All	0.658	0.810	<.001	41	view →
KIRC	DFS	Quartile	IV	0.183	0.482	.004	38	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	24	view →
HNSC	DFS	Median	III,IV	0.625	0.506	.003	18	view →
OV	DFS	Tertile	III,IV	0.189	0.115	.010	16	view →
SKCM	OS	Quartile	III,IV	0.864	0.675	.010	14	view →
PAAD	DFS	Median	All	0.375	0.198	.014	10	view →
GBM	OS	Tertile	All	0.269	0.453	.012	9	view →
MESO	DFS	Quartile	IV	0.075	0.471	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPS20P22–UVM (DFS)

Open the UVM breakdown →